Manual on the proper use of yttrium-90-labeled anti-P-cadherin antibody injection for radionuclide therapy in clinical trials

We present the guideline for use of yttrium-90-labeled anti-P-cadherin antibody injection for radionuclide therapy in clinical trials on the basis of radiation safety issues in Japan. This guideline was prepared by a study supported by the Ministry of Health, Labour, and Welfare, and approved by the...

Descripción completa

Detalles Bibliográficos
Autores principales: Hosono, Makoto, Ikebuchi, Hideharu, Kinuya, Seigo, Yanagida, Sachiko, Nakamura, Yoshihide, Yamada, Takahiro, Sakaguchi, Kenta, Sugano, Hiroyasu, Kojima, Kiyotaka, Hatazawa, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2019
Materias:
Special Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6823325/
https://www.ncbi.nlm.nih.gov/pubmed/31606788
http://dx.doi.org/10.1007/s12149-019-01409-x
_version_ 1783464505828704256
author Hosono, Makoto
Ikebuchi, Hideharu
Kinuya, Seigo
Yanagida, Sachiko
Nakamura, Yoshihide
Yamada, Takahiro
Sakaguchi, Kenta
Sugano, Hiroyasu
Kojima, Kiyotaka
Hatazawa, Jun
author_facet Hosono, Makoto
Ikebuchi, Hideharu
Kinuya, Seigo
Yanagida, Sachiko
Nakamura, Yoshihide
Yamada, Takahiro
Sakaguchi, Kenta
Sugano, Hiroyasu
Kojima, Kiyotaka
Hatazawa, Jun
author_sort Hosono, Makoto
collection PubMed
description We present the guideline for use of yttrium-90-labeled anti-P-cadherin antibody injection for radionuclide therapy in clinical trials on the basis of radiation safety issues in Japan. This guideline was prepared by a study supported by the Ministry of Health, Labour, and Welfare, and approved by the Japanese Society of Nuclear Medicine. Treatment using yttrium-90-labeled anti-P-cadherin antibody injection in Japan should be carried out according to this guideline. Although this guideline is applied in Japan, the issues for radiation protection shown here are considered internationally useful as well. Only the original Japanese version is the formal document.
format Online
Article
Text
id pubmed-6823325
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer Singapore
record_format MEDLINE/PubMed
spelling pubmed-68233252019-11-06 Manual on the proper use of yttrium-90-labeled anti-P-cadherin antibody injection for radionuclide therapy in clinical trials Hosono, Makoto Ikebuchi, Hideharu Kinuya, Seigo Yanagida, Sachiko Nakamura, Yoshihide Yamada, Takahiro Sakaguchi, Kenta Sugano, Hiroyasu Kojima, Kiyotaka Hatazawa, Jun Ann Nucl Med Special Article We present the guideline for use of yttrium-90-labeled anti-P-cadherin antibody injection for radionuclide therapy in clinical trials on the basis of radiation safety issues in Japan. This guideline was prepared by a study supported by the Ministry of Health, Labour, and Welfare, and approved by the Japanese Society of Nuclear Medicine. Treatment using yttrium-90-labeled anti-P-cadherin antibody injection in Japan should be carried out according to this guideline. Although this guideline is applied in Japan, the issues for radiation protection shown here are considered internationally useful as well. Only the original Japanese version is the formal document. Springer Singapore 2019-10-12 2019 /pmc/articles/PMC6823325/ /pubmed/31606788 http://dx.doi.org/10.1007/s12149-019-01409-x Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Special Article
Hosono, Makoto
Ikebuchi, Hideharu
Kinuya, Seigo
Yanagida, Sachiko
Nakamura, Yoshihide
Yamada, Takahiro
Sakaguchi, Kenta
Sugano, Hiroyasu
Kojima, Kiyotaka
Hatazawa, Jun
Manual on the proper use of yttrium-90-labeled anti-P-cadherin antibody injection for radionuclide therapy in clinical trials
title Manual on the proper use of yttrium-90-labeled anti-P-cadherin antibody injection for radionuclide therapy in clinical trials
title_full Manual on the proper use of yttrium-90-labeled anti-P-cadherin antibody injection for radionuclide therapy in clinical trials
title_fullStr Manual on the proper use of yttrium-90-labeled anti-P-cadherin antibody injection for radionuclide therapy in clinical trials
title_full_unstemmed Manual on the proper use of yttrium-90-labeled anti-P-cadherin antibody injection for radionuclide therapy in clinical trials
title_short Manual on the proper use of yttrium-90-labeled anti-P-cadherin antibody injection for radionuclide therapy in clinical trials
title_sort manual on the proper use of yttrium-90-labeled anti-p-cadherin antibody injection for radionuclide therapy in clinical trials
topic Special Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6823325/
https://www.ncbi.nlm.nih.gov/pubmed/31606788
http://dx.doi.org/10.1007/s12149-019-01409-x
work_keys_str_mv AT hosonomakoto manualontheproperuseofyttrium90labeledantipcadherinantibodyinjectionforradionuclidetherapyinclinicaltrials
AT ikebuchihideharu manualontheproperuseofyttrium90labeledantipcadherinantibodyinjectionforradionuclidetherapyinclinicaltrials
AT kinuyaseigo manualontheproperuseofyttrium90labeledantipcadherinantibodyinjectionforradionuclidetherapyinclinicaltrials
AT yanagidasachiko manualontheproperuseofyttrium90labeledantipcadherinantibodyinjectionforradionuclidetherapyinclinicaltrials
AT nakamurayoshihide manualontheproperuseofyttrium90labeledantipcadherinantibodyinjectionforradionuclidetherapyinclinicaltrials
AT yamadatakahiro manualontheproperuseofyttrium90labeledantipcadherinantibodyinjectionforradionuclidetherapyinclinicaltrials
AT sakaguchikenta manualontheproperuseofyttrium90labeledantipcadherinantibodyinjectionforradionuclidetherapyinclinicaltrials
AT suganohiroyasu manualontheproperuseofyttrium90labeledantipcadherinantibodyinjectionforradionuclidetherapyinclinicaltrials
AT kojimakiyotaka manualontheproperuseofyttrium90labeledantipcadherinantibodyinjectionforradionuclidetherapyinclinicaltrials
AT hatazawajun manualontheproperuseofyttrium90labeledantipcadherinantibodyinjectionforradionuclidetherapyinclinicaltrials

Ejemplares similares